Advertisement

Spreading Depolarization during the Acute Stage of Experimental Subarachnoid Hemorrhage in Mice

  • Zelong Zheng
  • Michael Schoell
  • Renan Sanchez-Porras
  • Christian Diehl
  • Andreas Unterberg
  • Oliver W. Sakowitz
Chapter
Part of the Acta Neurochirurgica Supplement book series (NEUROCHIRURGICA, volume 127)

Abstract

Spreading depolarization (SD) has been suggested as a pathomechanism for delayed cerebral ischemia after subarachnoid hemorrhage (SAH). However, the role of SD during the acute phase of SAH is still unclear. The objective of this study was to investigate (a) the occurrence of SD with intrinsic optical signal (IOS) imaging, (b) the effect of ketamine on SD, and (c) the resulting brain edema (brain water content (BWC)) during the acute stage of experimental SAH in mice. SAH was elicited by the endovascular filament perforation method. After SAH or sham operation, ketamine or saline, 30 mg/kg, was given every half hour. Changes in tissue light reflectance were recorded with IOS. BWC was measured during the acute stage. Overall, 199 SDs occurred in SAH groups and 33 SDs appeared in sham groups. These SDs displayed distinct originating and spreading patterns. Compared with saline, ketamine decreased SD spread and influenced the amplitude, duration, and speed of SD. However, the occurrence of SD was not prevented by ketamine. Moreover, ketamine did not reduce BWC after SAH. These results demonstrate that SD occurs with a high incidence during the acute stage of SAH. SDs are heterogeneous in incidence, origination, and propagation. It remains unclear whether ketamine effects on SD may be viewed as therapeutically beneficial after SAH.

Keywords

Brain edema Ketamine Intrinsic optical signal imaging Spreading depolarization Subarachnoid hemorrhage 

Notes

Acknowledgments

The author, Zelong Zheng, thanks the Chinese Scholarship Council for financial support.

Conflict of Interest

None.

References

  1. 1.
    Amemori T, Bures J. Ketamine blockade of spreading depression: rapid development of tolerance. Brain Res. 1990;519:351–4.CrossRefGoogle Scholar
  2. 2.
    Amemori T, Gorelova NA, Bures J. Spreading depression in the olfactory bulb of rats: reliable initiation and boundaries of propagation. Neuroscience. 1987;22:29–36.CrossRefGoogle Scholar
  3. 3.
    Ba AM, Guiou M, Pouratian N, Muthialu A, Rex DE, Cannestra AF, Chen JW, Toga AW. Multiwavelength optical intrinsic signal imaging of cortical spreading depression. J Neurophysiol. 2002;88:2726–35.  https://doi.org/10.1152/jn.00729.2001.CrossRefPubMedGoogle Scholar
  4. 4.
    Beaulieu C, Busch E, de Crespigny A, Moseley ME. Spreading waves of transient and prolonged decreases in water diffusion after subarachnoid hemorrhage in rats. Magn Reson Med. 2000;44:110–6.CrossRefGoogle Scholar
  5. 5.
    Dohmen C, Sakowitz OW, Fabricius M, Bosche B, Reithmeier T, Ernestus RI, Brinker G, Dreier JP, Woitzik J, Strong AJ. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol. 2008;63:720–8.CrossRefGoogle Scholar
  6. 6.
    Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17:439–47.  https://doi.org/10.1038/nm.2333.CrossRefPubMedGoogle Scholar
  7. 7.
    Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, Lehmann T-N, Sarrafzadeh A, Willumsen L, Hartings JA. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain. 2006;129:3224–37.CrossRefGoogle Scholar
  8. 8.
    Hartings JA, Rolli ML, X-CM L, Tortella FC. Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection. J Neurosci. 2003;23:11602–10.CrossRefGoogle Scholar
  9. 9.
    Hernándéz-Cáceres J, Macias-González R, Brožek G, Bureš J. Systemic ketamine blocks cortical spreading depression but does not delay the onset of terminal anoxic depolarization in rats. Brain Res. 1987;437:360–4.CrossRefGoogle Scholar
  10. 10.
    Hertle DN, Dreier JP, Woitzik J, Hartings JA, Bullock R, Okonkwo DO, Shutter LA, Vidgeon S, Strong AJ, Kowoll C, Dohmen C, Diedler J, Veltkamp R, Bruckner T, Unterberg AW, Sakowitz OW. Effect of analgesics and sedatives on the occurrence of spreading depolarizations accompanying acute brain injury. Brain. 2012;135:2390–8.  https://doi.org/10.1093/brain/aws152.CrossRefPubMedGoogle Scholar
  11. 11.
    Hubschmann OR, Kornhauser D. Cortical cellular response in acute subarachnoid hemorrhage. J Neurosurg. 1980;52:456–62.  https://doi.org/10.3171/jns.1980.52.4.0456.CrossRefPubMedGoogle Scholar
  12. 12.
    Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? The Lancet Neurology. 2002;1:383–6.CrossRefGoogle Scholar
  13. 13.
    Krüger H, Heinemann U, Luhmann HJ. Effects of ionotropic glutamate receptor blockade and 5-HT1A receptor activation on spreading depression in rat neocortical slices. Neuroreport. 1999;10:2651–6.CrossRefGoogle Scholar
  14. 14.
    Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011;31:17–35.  https://doi.org/10.1038/jcbfm.2010.191.CrossRefPubMedGoogle Scholar
  15. 15.
    Martins-Ferreira H, Nedergaard M, Nicholson C. Perspectives on spreading depression. Brain Res Rev. 2000;32:215–34.CrossRefGoogle Scholar
  16. 16.
    Petzold GC, Windmüller O, Haack S, Major S, Buchheim K, Megow D, Gabriel S, Lehmann T-N, Drenckhahn C, Peters O. Increased extracellular K+ concentration reduces the efficacy of N-methyl-D-aspartate receptor antagonists to block spreading depression-like depolarizations and spreading ischemia. Stroke. 2005;36:1270–7.CrossRefGoogle Scholar
  17. 17.
    Sánchez-Porras R, Santos E, Schöll M, Stock C, Zheng Z, Schiebel P, Orakcioglu B, Unterberg AW, Sakowitz OW. The effect of ketamine on optical and electrical characteristics of spreading depolarizations in gyrencephalic swine cortex. Neuropharmacology. 2014;84:52–61.CrossRefGoogle Scholar
  18. 18.
    Sakowitz OW, Kiening KL, Krajewski KL, Sarrafzadeh AS, Fabricius M, Strong AJ, Unterberg AW, Dreier JP. Preliminary evidence that ketamine inhibits spreading depolarizations in acute human brain injury. Stroke. 2009;40:e519–22.  https://doi.org/10.1161/strokeaha.109.549303.CrossRefPubMedGoogle Scholar
  19. 19.
    Santos E, Schöll M, Sánchez-Porras R, Dahlem MA, Silos H, Unterberg A, Dickhaus H, Sakowitz OW. Radial, spiral and reverberating waves of spreading depolarization occur in the gyrencephalic brain. NeuroImage. 2014;99:244–55.CrossRefGoogle Scholar
  20. 20.
    Schmid RL, Sandler AN, Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain. 1999;82:111–25.CrossRefGoogle Scholar
  21. 21.
    Sehba FA, Hou J, Pluta RM, Zhang JH. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol. 2012;97:14–37.  https://doi.org/10.1016/j.pneurobio.2012.02.003.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Serrone JC, Maekawa H, Tjahjadi M, Hernesniemi J. Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions. Expert Rev Neurother. 2015;15:367–80.  https://doi.org/10.1586/14737175.2015.1018892.CrossRefPubMedGoogle Scholar
  23. 23.
    Thal SC, Sporer S, Klopotowski M, Thal SE, Woitzik J, Schmid-Elsaesser R, Plesnila N, Zausinger S. Brain edema formation and neurological impairment after subarachnoid hemorrhage in rats: laboratory investigation. J Neurosurg. 2009;111:988–94.CrossRefGoogle Scholar
  24. 24.
    van den Bergh WM, Zuur JK, Kamerling NA, van Asseldonk JT, Rinkel GJ, Tulleken CA, Nicolay K. Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg. 2002;97:416–22.  https://doi.org/10.3171/jns.2002.97.2.0416.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Zelong Zheng
    • 1
    • 2
  • Michael Schoell
    • 3
  • Renan Sanchez-Porras
    • 1
  • Christian Diehl
    • 1
  • Andreas Unterberg
    • 1
  • Oliver W. Sakowitz
    • 1
  1. 1.Department of NeurosurgeryHeidelberg University HospitalHeidelbergGermany
  2. 2.Department of NeurosurgeryGuangzhou First People’s Hospital, School of Medicine, South China University of TechnologyGuangzhouChina
  3. 3.Institute for Medical Biometry and Informatics, Heidelberg UniversityHeidelbergGermany

Personalised recommendations